About Joshua Boyce, MD

Dr. Boyce completed his residency in Pediatrics at the University of Massachusetts Medical Center, where he served as Pediatric Chief Resident. After two years in practice as a general pediatrician, he returned to academia where he completed fellowships in Pediatric Pulmonology at MGH, and Allergy and Immunology at the Brigham and Women's Hospital. He is presently the Albert L. Sheffer Professor of Medicine in the Field of Allergic Disease at Harvard Medical School, and the Chief of Allergy at the Brigham and Women's Hospital. He also directs a large and productive research program focused on understanding the immunologic basis of asthma and allergic diseases. He has trained many successful investigators and physicians in this field. He has been on the staff at MGHfC since 1991, maintaining  a practice focused on allergic diseases and asthma in children.  He has twice been recognized by Boston Magazine as one of the top specialists in his field.

Clinical Interests:




MGHfc at Newton Wellesley Hospital
2014 Washington Street,
Newton, MA 02462
Fax: 617-724-3948

Medical Education

  • MD, UMASS Medical School
  • Residency, UMASS School of Medicine
  • Fellowship, Brigham and Women's Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Pediatric Pulmonology, American Board of Pediatrics
  • Allergy & Immunology, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • View my most recent publications at PubMed

    Selected Publications:

    • Cahill KN, Katz HR, Cui J, Lai J, Kazani S, Crosby-Thompson A, Garofalo D, Castro M, Jarjour N, DiMango E, Erzurum S, Trevor JL, Shenoy K, Chinchilli VM, Weschler ME, Laidlaw TM, Boyce JA, Israel E. KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma. N. Engl. J. Med. 2017 76(20):1911-1920.
    • Liu T, Barrett NA, Kanaoka Y, Yoshimoto E, Garofalo D, Feng C, Boyce JA. Type 2 cysteinyl leukotrienes drive IL-33-dependent type 2 immunopathology and aspirin sensitivity. J. Immunol. 2018 200:915-927.
    • Pan D, Buchheit K, Samuchiwal S, Liu T, Cirka H, Raff H, Boyce JA. Cyclooxygenase 1 mediates IL-33-induced extracellular signal regulated kinase activation in mast cells; Implications for aspirin sensitivity. J. Allergy Clin. Immunol. 2018 (in press)
    • Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, Kothari P, Raby BA, Israel E, Boyce JA. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J. Allergy Clin. Immunol. 2018 (in press)
    • Ordovas-Montanez J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, Wadsworth MH, Hughes TK, Kazer SW, Yoshimoto E, Cahill KN, Bhattacharya N, Katz HR, Berger B, Laidlaw TM, Boyce JA, Barrett NA, Shalek AK. Allergic inflammatory memory in human respiratory progenitor cells. Nature 2018 (in press)